JP Morgan Chase
LABD icon

JP Morgan Chase’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

JP Morgan Chase’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,250
Closed -$237K – 7732
2025
Q4 		$237K Buy
11,250
+4,447
+65% +$121K ﹤0.01% 5449
2025
Q3 		$275K Buy
6,803
+6,713
+7,459% +$389K ﹤0.01% 5342
2025
Q2 		$6.73K Buy
+90
New +$7.96K ﹤0.01% 6376
2021
Q2 		– Sell
-6
Closed -$1K – 6478
2021
Q1 		$1K Buy
+6
New +$1.16K ﹤0.01% 5981

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JP Morgan Chase's LABD Position: Q1 2026 in Review

JP Morgan Chase sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2026, closing a stake of 11,250 shares — an estimated $237K sold.

JP Morgan Chase first reported a position in LABD in Q1 2021 and held it in 4 quarters. The position peaked at $275K in Q3 2025. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • JP Morgan Chase reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 11,250 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $237K.
  • JP Morgan Chase first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2021 and held it in 4 quarters.
  • JP Morgan Chase's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $275K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.